Remove us-news biden-administration
article thumbnail

Biden names 10 drugs for first negotiations to cut Medicare prices

The Guardian - Pharmaceutical Industry

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional The Biden administration has selected 10 drugs for the first round of price negotiations between Medicare and pharmaceutical companies in an effort to lower costs for seniors, it announced on Tuesday.

article thumbnail

STAT+: Pharmalittle: Novartis is latest drugmaker to sue over Medicare negotiations; Illumina names a new CEO

STAT

Please feel free to join us. The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration last Tuesday released its list of 10 prescription medicines that will be subject to price negotiations by the Medicare health program, which covers 66 million people. And please do keep in touch.

74
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: Mid-year price hikes for U.S. drugs reaches new heights; onetime biotech CEO Vivek Ramaswamy sparks debate at GOP debate

STAT

But like us, the news isn’t on holiday, and we have a packed edition for you.   A new analysis of mid-year price hikes has found that, despite policy changes under the Inflation Reduction Act, drug prices are on the rise , STAT reports. Here are the latest headlines. 

81
article thumbnail

US orders 500m Pfizer/BioNTech COVID jabs for developing nations

pharmaphorum

The US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given to around 100 countries via the COVAX donation programme over the next two years. The US previously said it would donate 80 million doses from its national supply to COVAX by the end of this month.

article thumbnail

FDA schedules adcomm for Pfizer’s COVID booster filing

pharmaphorum

The news comes as Moderna has just announced the submission of initial data to the FDA for its own COVID-19 vaccine booster. The FDA has already issued an emergency use authorisation (EUA) for third doses of the Pfizer/BioNTech and Moderna jabs, but only for people with compromised immune systems.

FDA 71
article thumbnail

Another Twitter blow to science as Musk ends COVID misinformation policy

pharmaphorum

The news comes not many months after the company revealed that it had suspended more than 11,000 accounts for COVID misinformation that breached its ‘five-strike’ policy. US Congresswoman Marjorie Taylor Greene also had her personal account revoked for repeatedly violating Twitter’s COVID rules.

article thumbnail

HHS’ Recommendation to Reschedule Cannabis to Schedule III Raises Questions

The FDA Law Blog

Last October President Joe Biden asked the Secretary of the Department of Health and Human Services (“HHS”) and the Attorney General to “initiate the administrative process to review expeditiously how marijuana is scheduled under federal law.” Statement from President Biden on Marijuana Reform, White House (Oct.